Home/Optimvia/Mick Kowitz

MK

Mick Kowitz

Director

Therapeutic Areas

Anticoagulation Thrombosis

Optimvia Pipeline

Drug	Indication	Phase
Biosynthetic Heparin	Anticoagulation/Antithrombosis	Pre-clinical

Leadership Team at Optimvia

Keith M. Kleeman

CEO and Chair of the Board

James E. Rothman, PhD

Steve Geis, PhD, MD

View full Optimvia profile